Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...
Clinical trials are the irreplaceable engine of drug development and a bedrock of modern medicine, yet patient enrollment ...
As the use of digital tools continues to expand within clinical research, effective data management for eCOA systems is more important than ever. From initial design and system setup to ongoing ...
The oral presentation, titled, “¹⁸⁶Rhenium-Nanoliposomes (¹⁸⁶RNL) for the Treatment of Leptomeningeal Metastases: Translational Insights from Clinical and Preclinical Models,” was delivered by ...
Entrada Therapeutics, Inc. TRDA stock is trading lower on Thursday as the stock reacts to news regarding its clinical trial ...
Lastly, a broader view of clinical outcomes and operational insights is a cornerstone to product value translation. Gathering ...
In the last decade, the volume of clinical trial data has surged, presenting unprecedented challenges for sponsors and contract research organizations (CROs). The task of collecting, cleaning, ...
Clinical Trials Arena on MSN
enGene reports interim data from LEGEND trial of detalimogene voraplasmid
The trial enrolled 125 patients, with detalimogene achieving 54% CR any time and 43% at six months.
Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, ...
Women were generally excluded from clinical trials until the 1990s; in 1993, the NIH inclusion policy was codified into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results